Sakar Healthcare Reports Q1 Unaudited Results; Announces 22nd AGM Details
Sakar Healthcare Limited has reported its unaudited financial results for the quarter ended June 30, 2026. The company's Board of Directors held a meeting on July 24, 2026, where they reviewed and approved these results. Additionally, the Board decided to convene the 22nd Annual General Meeting (AGM) of the Shareholders.The company also announced important corporate governance decisions, including the appointment of a Secretarial Auditor and Cost Auditors for the upcoming fiscal year.
Financial Performance Highlights
Sakar Healthcare's unaudited standalone and consolidated financial results reflect key performance metrics across the reporting periods: Quarter ending June 30, 2026, compared to March 31, 2026, and June 30, 2025.The financial data, presented in Lakh Rupees (Rs.), highlights operating figures including revenue from operations, total income, expenses, and profit for the period.
Standalone Financial Results Snapshot (in Rs. Lakh)
| Particulars | Quarter ended on 30-06-2026 (Unaudited) | Quarter ended on 31-03-2026 (Audited) | Quarter ended on 30-06-2025 (Unaudited) |
|---|---|---|---|
| Revenue from operations | 7297.25 | 7109.70 | 5273.62 |
| Total Income | 7451.64 | 7126.82 | 5313.01 |
| Total Expenses | 5993.57 | 5320.82 | 4774.53 |
| Profit before tax (QoP) | 1458.07 | 1806.00 | 538.48 |
| Profit for the period from continuing operations | 1028.49 | 1102.43 | 467.13 |
Consolidated Financial Results Snapshot (in Rs. Lakh)
The consolidated results, which include the wholly owned subsidiary M/s Sakar Oncology Private Limited, show corresponding operational data:
| Particulars | Quarter ended on 30-06-2026 (Unaudited) | Quarter ended on 31-03-2026 (Audited) | Quarter ended on 30-06-2025 (Unaudited) |
|---|---|---|---|
| Revenue from operations | 7297.25 | 7109.70 | 5273.62 |
| Total Income | 7451.64 | 7126.82 | 5313.01 |
| Total Expenses | 5993.57 | 5320.82 | 4774.53 |
| Profit for the period (from continuing operations) | 1028.49 | 1102.43 | 467.13 |
The company’s paid-up equity shares capital stands at 2224.99 Lakh per share in both standalone and consolidated statements.
Corporate Governance Updates
During the board meeting, two key appointments were made by the Board of Directors:- Secretarial Auditor: M/s Kashyap R. Mehta & Partners, Practising Company Secretaries, was appointed as the Secretarial Auditors for a term of five consecutive years, commencing from the financial year 2026-27 to 2030-31, subject to shareholder approval at the ensuing AGM.
- Cost Auditors: M/s Dalwadi & Associates, Cost Accountants, was appointed as the Cost Auditors for the financial year 2026-27.
Annual General Meeting (AGM) Details
The Board of Directors decided to convene the 22nd Annual General Meeting (AGM) on Tuesday, September 22, 2026, at 12:30 p.m., utilizing Video Conferencing and Other Audio Visual Means.Details regarding remote e-voting for the AGM are provided below:
| Parameter | Detail |
|---|---|
| Date & Time of commencement Remote e-voting | September 19, 2026 at 9:00 a.m. |
| Cut-off date for determining rights of entitlement of Remote e-voting | To be specified |
| E-voting system during the AGM shall not be allowed beyond | 15 Minutes after the conclusion of AGM |
SAKAR Stock Price Movement
As of 12:41 PM, shares of Sakar Healthcare Limited are shedding value, slipping by 2.34% in live trading, currently trading at ₹808.25. The stock has seen significant activity during the session, with a total traded volume reaching 150,415 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.